Natixis Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-179,666
Closed -$7.33M 1308
2021
Q1
$7.33M Buy
179,666
+10,603
+6% +$402K 0.04% 471
2020
Q4
$7.65M Sell
169,063
-15,740
-9% -$597K 0.04% 427
2020
Q3
$6.54M Buy
184,803
+2,715
+1% +$98.1K 0.04% 437
2020
Q2
$6.87M Buy
182,088
+16,973
+10% +$559K 0.05% 409
2020
Q1
$4.77M Buy
165,115
+1,081
+0.7% +$43.7K 0.04% 465
2019
Q4
$8.51M Buy
164,034
+11,470
+8% +$666K 0.06% 355
2019
Q3
$8.37M Sell
152,564
-4,995
-3% -$256K 0.07% 323
2019
Q2
$6.4M Buy
157,559
+101,237
+180% +$3.69M 0.05% 385
2019
Q1
$1.7M Sell
56,322
-68,658
-55% -$2.35M 0.01% 808
2018
Q4
$4.2M Sell
124,980
-9,538
-7% -$344K 0.04% 459
2018
Q3
$5.67M Buy
134,518
+1,842
+1% +$72.8K 0.05% 419
2018
Q2
$4.25M Buy
132,676
+6,388
+5% +$263K 0.04% 519
2018
Q1
$6.28M Buy
126,288
+6,835
+6% +$386K 0.06% 360
2017
Q4
$6.44M Buy
119,453
+5,919
+5% +$328K 0.07% 344
2017
Q3
$6.58M Buy
113,534
+22,225
+24% +$1.16M 0.07% 346
2017
Q2
$4.5M Buy
91,309
+3,311
+4% +$152K 0.05% 465
2017
Q1
$3.82M Buy
+87,998
New +$4.2M 0.04% 512

Other funds holding ANIK